MPS Summit Takeaways | Q& A with AxoSim Lead Scientist Corey Rountree, PhD
News and BlogAxoSim Lead Scientist Corey Rountree, PhD, recaps his experiences from the inaugural MPS World Summit held in New Orleans in May 2022. […]
Read MoreAxoSim empowers advancements in human neuroscience and accelerates the drug development process through our NerveSim® and BrainSim® drug discovery platforms
Learn MoreOur technology enables researchers to predict human outcomes in the lab. We deliver accurate preclinical testing to help develop safer, more effective drugs.
Almost 90% of drugs that look promising in animal models fail when tested in humans, driving up the average cost and time of new drug development to $2.6 billion and 10 years or more. We deliver predictive human data in just weeks and at a fraction of the cost of in vivo studies.
Achieve the predictive readouts critical to your R&D success. We deliver clinically-relevant functional and structural metrics to improve success rates.
AxoSim's NerveSim® platform facilitates prediction of both clinical neurotoxicity and efficacy in human neurodegenerative disease models earlier in the drug development pipeline.
BrainSim® is a high quality 3D miniature brain organoid designed to serve as a human-relevant model in preclinical drug discovery.
AxoSim Lead Scientist Corey Rountree, PhD, recaps his experiences from the inaugural MPS World Summit held in New Orleans in May 2022. […]
Read MoreAngela Cheramie was born in 1960 in Galliano, Louisiana, about an hour and half south of New Orleans. She was adopted at […]
Read MoreFrom May 30 to June 3, AxoSim is a sponsor and co-host of the inaugural MPS World Summit which we are honored to have in our […]
Read MoreWe are proud to announce our published paper: Morphine-sensitive synaptic transmission emerges in embryonic rat microphysiological model of lower afferent nociceptive signaling […]
Read More